Conatus Pharmaceuticals Inc. (CNAT)

[fishhunter]

I don't know what a "double blind" study is.

And I don't think it matters because the data IS coming into somebody somewhere for tabulation and analysis. Whoever that somebody is or that company is - they know or somebody knows well ahead of the press release that will tell the rest of us.

So, who is the somebody that is receiving data today? Is it a 3rd party company? Is it the FDA? Is it a independent subset of Conatus? What is the structure and how does one keep the company from knowing? At some point, Conatus is involved to analyze and it is well ahead of the reporting date. Has to be.